Jan Taplick
Impact in
- Geriatrics and Gerontology top 10%
-
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Genomics and Chromatin Dynamics
- DNA Repair Mechanisms
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 4
- DNA Repair Mechanisms 1
- Epigenetics and DNA Methylation 1
- Oncology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Christian Seiser (4 shared papers)Moshe Oren (3 shared papers)Thomas Lechner (2 shared papers)Xinjiang Wang (1 shared paper)Gil Blander (1 shared paper)Matthew D. Gray (1 shared paper)Yaron Daniely (1 shared paper)Stefan Bartl (1 shared paper)
- Journals
- FEBS Letters (2 papers)Annals of the New York Academy of Sciences (1 paper)British Journal of Haematology (1 paper)Molecular and Cellular Biology (1 paper)Biochemistry (1 paper)
- Partner nations
- AustriaIsraelNetherlands
In The Last Decade
Jan Taplick
8 papers receiving 615 citations
Peers
Comparison fields: 5 of 66
- Geriatrics and Gerontology 29
- Molecular Biology 539
- Oncology 183
- Aging 7
- Cancer Research 48
Countries citing papers authored by Jan Taplick
This map shows the geographic impact of Jan Taplick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Taplick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Taplick more than expected).
Fields of papers citing papers by Jan Taplick
This network shows the impact of papers produced by Jan Taplick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Taplick. The network helps show where Jan Taplick may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Taplick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 111 | |
| 2 | 1997 | 106 | |
| 3 | 2002 | 91 | |
| 4 | 2001 | 90 | |
| 5 | 2004 | 86 | |
| 6 | 1999 | 60 | |
| 7 | 2001 | 43 | |
| 8 | 1998 | 35 |
About Jan Taplick
Jan Taplick is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Plant Science, having authored 8 papers that have together received 622 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (3 papers), Acute Myeloid Leukemia Research (1 paper), DNA Repair Mechanisms (1 paper), Epigenetics and DNA Methylation (1 paper), NF-κB Signaling Pathways (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Geriatrics and Gerontology (29 citations), Molecular Biology (539 citations), Oncology (183 citations), Aging (7 citations) and Cancer Research (48 citations). Jan Taplick has collaborated with scholars based in Austria, Israel and Netherlands. Frequent co-authors include Christian Seiser, Moshe Oren, Thomas Lechner, Xinjiang Wang, Gil Blander, Matthew D. Gray, Yaron Daniely, Stefan Bartl, Karl Kuchler and Markus Posch. Their work appears in journals such as FEBS Letters, Annals of the New York Academy of Sciences, British Journal of Haematology, Molecular and Cellular Biology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.